Acumen Research and Consulting has announced the addition of the “Active Pharmaceutical Ingredient (API) Market (By Type of Synthesis: Biotech [Monoclonal antibodies, Recombinant proteins, Vaccines], Synthetic ; By Type of Manufacturer: Captive APIs, Merchant APIs; By Type: Innovative APIs, Generic APIs; By Application: Cardiology [Generic, Innovative], Orthopedic [Generic, Innovative], Oncology [Generic, Innovative], Endocrinology [Generic, Innovative], Pulmonology [Generic, Innovative], Gastroenterology [Generic, Innovative], CNS & Neurology[Generic, Innovative], Nephrology [Generic, Innovative], Ophthalmology [Generic, Innovative], Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 – 2026″ report to their offering. Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
The global Active Pharmaceutical Ingredient market is forecasted to grow at a stable CAGR around 6.5% during the forecast period 2018 to 2026 and reach the market value around USD 260 billion by 2026. Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/reques t-sample/146 Growing geriatric population across the globe is also likely to contribute to the market expansion. Estimates published by the WHO suggest that the worldwide base of populace pertaining to the age group of 65 years and above is likely to rise from 7% in 2000 to 16% in 2050. Latin America, in particular, is projected to witness fastest growth, in terms of geriatric population. Patent expiration of blockbuster drugs, growing outsourcing activities due to high manufacturing costs, and stringent regulations for API production are expected to intensify the market competition. As part of strategic geographic expansion, many companies are setting up manufacturing plants in the developing regions like Asia Pacific. Increasing geriatric populace over the globe is additionally liable to add to the market extension. Evaluations distributed by the WHO recommend that the worldwide base of populace relating to the age gathering of 65 years or more is required to ascend from 7% in 2000 to 16% in 2050. Latin America, specifically, is anticipated to observe quickest development, regarding geriatric populace. Patent lapse of blockbuster drugs, developing redistributing exercises because of high assembling expenses, and stringent guidelines for API production are anticipated to heighten the market rivalry. As a major aspect of key geographic extension, numerous organizations are setting up manufacturing plants in the emerging areas like Asia Pacific.
Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/activepharmaceutical-ingredients-api-market Cardiology is Likely to Clutch the Principal Market Share in the Application Category The active pharmaceutical ingredients market, by application, is commanded by the cardiology fragment, because of the tremendous populace utilizing different CVD drugs. This portion is anticipated to observe a CAGR of around 6% amid the estimate time frame. Coronary heart disease (CHD) is the most widely recognized sort of cardiovascular infection, with a loss of life of more than 370,000 individuals, every year, in the United States alone. As indicated by the American Heart Association (AHA), cardiovascular infection represents 17.3 million passings for every year. The Center for Disease Control and Prevention expresses that around 610,000 individuals kick the bucket of heart illnesses in the United States each year, i.e., one in each four passings can be ascribed to cardiovascular diseases (CVDs). Cholesterol reducers and circulatory strain lowering medications are the key medication classes under CVS. Cholesterol reducers, particularly Statins, are driving the CVS portion, and have risen as the most essential group of medications among the cholesterol and triglycerides reducers. Medicinal services expenditure for hypertension was USD 23 to 26 billion out of 2017, in the developed markets alone. Another USD 14 to 17 billion was spent in 2017 in the pharmerging markets. The high use on the cardiovascular class features the rising interest for APIs in the equivalent.
‌. Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
Explore Our Market Blog@ https://www.acumenresearchandconsulting.com/blogs 2018, North America Held the Most Absconding Piece of Pie North America conquered the worldwide market and is anticipated to lose piece of the pie before the finish of 2026. The market in North America is principally determined by a fast increment in the occurrence of diabetes and cancer and an ascent in the geriatric populace in the U.S. In addition, an expansion in the demand for inventive medicine in the U.S. is anticipated to fuel the active pharmaceutical ingredients market in the nation amid the conjecture time frame. The market in Asia Pacific is anticipated to extend at a fast pace amid the conjecture time frame. In Asia Pacific, Japan commanded the active pharmaceutical ingredients, while the market in China is assessed to grow at an exponential CAGR amid the conjecture time frame. Market Players The Active Pharmaceutical Ingredient (API) market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are AbbVie Inc.; Merck & Co., Inc.; Boehringer Ingelheim International GmbH; Teva Pharmaceutical Industries Ltd; Cipla, Inc.; Albemarle Corporation; Bristol-Myers Squibb Company; Sun Pharmaceutical Industries Ltd.; Mylan N.V.; Aurobindo Pharma; and Dr. Reddy’s Laboratories Ltd.
‌. Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
Browse All official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/pressreleases TABLE OF CONTENT CHAPTER 1. INDUSTRY OVERVIEW 1.1. Definition and Scope 1.1.1. Definition of Active Pharmaceutical Ingredient (API) 1.1.2. Market Segmentation 1.1.3. List of Abbreviations 1.2. Summary 1.2.1. Market Snapshot 1.2.2. Active Pharmaceutical Ingredient (API) Market By Type of Synthesis 1.2.2.1. Global Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate Comparison By Type of Synthesis (2015-2026) 1.2.2.2. Global Active Pharmaceutical Ingredient (API) Market Revenue Share By Type of Synthesis in 2017 1.2.2.3. Biotech 1.2.2.3.1. Monoclonal antibodies 1.2.2.3.2. Recombinant proteins 1.2.2.3.3. Vaccines 1.2.2.4. Synthetic 1.2.3. Active Pharmaceutical Ingredient (API) Market By Type of Manufacturer 1.2.3.1. Global Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate Comparison By Type of Manufacturer (2015-2026) 1.2.3.2. Global Active Pharmaceutical Ingredient (API) Market Revenue Share By Type of Manufacturer in 2017 1.2.3.3. Captive APIs 1.2.3.4. Merchant APIs 1.2.4. Active Pharmaceutical Ingredient (API) Market By Type 1.2.4.1. Global Active Pharmaceutical Ingredient (API) Market Revenue and Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
Growth Rate Comparison By Type (2015-2026) 1.2.4.2. Global Active Pharmaceutical Ingredient (API) Market Revenue Share By Type in 2017 1.2.4.3. Innovative APIs 1.2.4.4. Generic APIs 1.2.5. Active Pharmaceutical Ingredient (API) Market By Application 1.2.5.1. Global Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate Comparison By Application (2015-2026) 1.2.5.2. Global Active Pharmaceutical Ingredient (API) Market Revenue Share By Application in 2017 1.2.5.3. Cardiology 1.2.5.4. Orthopedic 1.2.5.5. Oncology 1.2.5.6. Endocrinology 1.2.5.7. Pulmonology 1.2.5.8. Gastroenterology 1.2.5.9. CNS & Neurology 1.2.5.10. Nephrology 1.2.5.11. Ophthalmology 1.2.5.12. Others 1.2.6. Active Pharmaceutical Ingredient (API) Market by Geography 1.2.6.1. Global Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate Comparison by Geography (2015-2026) 1.2.6.2. North America Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate (2015-2026) 1.2.6.3. Europe Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate (2015-2026) 1.2.6.4. Asia-Pacific Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate (2015-2026) 1.2.6.5. Latin America Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate (2015-2026) Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
1.2.6.6. Middle East and Africa (MEA) Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate (2015-2026) CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS 2.1. Market Drivers 2.2. Restraints and Challenges 2.3. Growth Opportunities 2.4. Porter’s Five Forces Analysis 2.4.1. Bargaining Power of Suppliers 2.4.2. Bargaining Power of Buyers 2.4.3. Threat of Substitute 2.4.4. Threat of New Entrants 2.4.5. Degree of Competition 2.5. Value Chain Analysis 2.6. Cost Structure Analysis 2.6.1. Raw Material and Suppliers 2.6.2. Manufacturing Process Analysis 2.7. Regulatory Compliance 2.8. Competitive Landscape, 2017 2.8.1. Player Positioning Analysis 2.8.2. Key Strategies Adopted By Leading Players CHAPTER 3. MANUFACTURING PLANTS ANALYSIS 3.1. Capacity and Commercial Production Date of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2017 3.2. Manufacturing Plants Distribution of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2017 3.3. R&D Status and Technology Source of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2017 3.4. Raw Materials Sources Analysis of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2017 Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
CHAPTER 4. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY TYPE OF SYNTHESIS 4.1. Global Active Pharmaceutical Ingredient (API) Revenue By Type of Synthesis 4.2. Biotech 4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.2.3. Monoclonal antibodies 4.2.4. Recombinant proteins 4.2.5. Vaccines 4.3. Synthetic 4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) CHAPTER 5. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY TYPE OF MANUFACTURER 5.1. Global Active Pharmaceutical Ingredient (API) Revenue By Type of Manufacturer 5.2. Captive APIs 5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 5.3. Merchant APIs 5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) CHAPTER 6. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY TYPE 6.1. Global Active Pharmaceutical Ingredient (API) Revenue By Type 6.2. Innovative APIs 6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 6.3. Generic APIs Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) CHAPTER 7. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY APPLICATION 7.1. Global Active Pharmaceutical Ingredient (API) Revenue By Application 7.2. Cardiology 7.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 7.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 7.2.3. Generic 7.2.4. Innovative 7.3. Orthopedic 7.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 7.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 7.3.3. Generic 7.3.4. Innovative 7.4. Oncology 7.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 7.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 7.4.3. Generic 7.4.4. Innovative 7.5. Endocrinology 7.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 7.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 7.5.3. Generic 7.5.4. Innovative 7.6. Pulmonology 7.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 7.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 7.6.3. Generic 7.6.4. Innovative 7.7. Gastroenterology Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
7.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 7.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 7.7.3. Generic 7.7.4. Innovative 7.8. Others 7.8.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 7.8.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) CHAPTER 8. NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY 8.1. North America Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 – 2026 ($Million) 8.2. North America Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%) 8.3. U.S. 8.3.1. U.S. Active Pharmaceutical Ingredient (API) Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 8.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 8.3.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 8.3.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 8.4. Canada 8.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 8.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 8.4.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 8.4.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 8.5. Mexico 8.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 8.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
8.5.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 8.5.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) CHAPTER 9. EUROPE ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY 9.1. Europe Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 – 2026 ($Million) 9.2. Europe Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%) 9.3. UK 9.3.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 9.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 9.3.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 9.3.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 9.4. Germany 9.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 9.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 9.4.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 9.4.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 9.5. France 9.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 9.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 9.5.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 9.5.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 9.6. Spain 9.6.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 9.6.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 9.6.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
9.6.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 9.7. Rest of Europe 9.7.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 9.7.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 9.7.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 9.7.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) CHAPTER 10. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY 10.1. Asia-Pacific Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 – 2026 ($Million) 10.2. Asia-Pacific Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%) 10.3. China 10.3.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 10.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 10.3.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 10.3.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 10.4. Japan 10.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 10.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 10.4.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 10.4.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 10.5. India 10.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 10.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
($Million) 10.5.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 10.5.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 10.6. Australia 10.6.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 10.6.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 10.6.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 10.6.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 10.7. South Korea 10.7.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 10.7.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 10.7.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 10.7.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 10.8. Rest of Asia-Pacific 10.8.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 10.8.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 10.8.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 10.8.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) CHAPTER 11. LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY 11.1. Latin America Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 – 2026 ($Million) 11.2. Latin America Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%) 11.3. Brazil Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
11.3.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 11.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 11.3.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 11.3.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 11.4. Argentina 11.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 11.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 11.4.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 11.4.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 11.5. Rest of Latin America 11.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 11.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 11.5.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 11.5.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) CHAPTER 12. MIDDLE EAST ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY 12.1. Middle East Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 – 2026 ($Million) 12.2. Middle East Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%) 12.3. Saudi Arabia 12.3.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 12.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
12.3.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 12.3.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 12.4. UAE 12.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 12.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 12.4.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 12.4.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 12.5. Rest of Middle East 12.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 12.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 12.5.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 12.5.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) CHAPTER 13. AFRICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY 13.1. Africa Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 – 2026 ($Million) 13.2. Africa Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%) 13.3. South Africa 13.3.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 13.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 13.3.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 13.3.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 13.4. Egypt 13.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
($Million) 13.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 13.4.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 13.4.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 13.5. Rest of Africa 13.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 – 2026 ($Million) 13.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 – 2026 ($Million) 13.5.3. Market Revenue and Forecast By Type , 2015 – 2026 ($Million) 13.5.4. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) CHAPTER 14. COMPANY PROFILE 14.1. AbbVie Inc. 14.1.1. Company Snapshot 14.1.2. Overview 14.1.3. Financial Overview 14.1.4. Product Portfolio 14.1.5. Key Developments 14.1.6. Strategies 14.2. Merck & Co., Inc. 14.2.1. Company Snapshot 14.2.2. Overview 14.2.3. Financial Overview 14.2.4. Product Portfolio 14.2.5. Key Developments 14.2.6. Strategies 14.3. Boehringer Ingelheim International GmbH 14.3.1. Company Snapshot 14.3.2. Overview 14.3.3. Financial Overview Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
14.3.4. Product Portfolio 14.3.5. Key Developments 14.3.6. Strategies 14.4. Teva Pharmaceutical Industries Ltd; Cipla, Inc. 14.4.1. Company Snapshot 14.4.2. Overview 14.4.3. Financial Overview 14.4.4. Product Portfolio 14.4.5. Key Developments 14.4.6. Strategies 14.5. Albemarle Corporation 14.5.1. Company Snapshot 14.5.2. Overview 14.5.3. Financial Overview 14.5.4. Product Portfolio 14.5.5. Key Developments 14.5.6. Strategies 14.6. Bristol-Myers Squibb Company 14.6.1. Company Snapshot 14.6.2. Overview 14.6.3. Financial Overview 14.6.4. Product Portfolio 14.6.5. Key Developments 14.6.6. Strategies 14.7. Sun Pharmaceutical Industries Ltd. 14.7.1. Company Snapshot 14.7.2. Overview 14.7.3. Financial Overview 14.7.4. Product Portfolio 14.7.5. Key Developments 14.7.6. Strategies 14.8. Mylan N.V. Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
14.8.1. Company Snapshot 14.8.2. Overview 14.8.3. Financial Overview 14.8.4. Product Portfolio 14.8.5. Key Developments 14.8.6. Strategies 14.9. Aurobindo Pharma 14.9.1. Company Snapshot 14.9.2. Overview 14.9.3. Financial Overview 14.9.4. Product Portfolio 14.9.5. Key Developments 14.9.6. Strategies 14.10. Dr. Reddy’s Laboratories Ltd. 14.10.1. Company Snapshot 14.10.2. Overview 14.10.3. Financial Overview 14.10.4. Product Portfolio 14.10.5. Key Developments 14.10.6. Strategies CHAPTER 15. RESEARCH APPROACH 15.1. Research Methodology 15.1.1. Initial Data Search 15.1.2. Secondary Research 15.1.3. Primary Research 15.2. Assumptions and Scope Buy this premium research report@ https://www.acumenresearchandconsulting.com/buynow/0/146
Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157